Double-Blind, Randomized, Placebo-Controlled Phase IIa Clinical Trial to Investigate the Safety and Immunogenicity of RUTI Therapeutic Vaccination in Patients With MDR-TB After Successful Intensive-phase Treatment

Status: Discontinued

Phase of Trial: Phase II

Latest Information Update: 07 Jul 2022

Price :

$35 ^*

Note:

Adis is an information provider.
Final gross price and currency may vary according to local VAT and billing address.
Your purchase entitles you to full access to the information contained in our trial profile at the time of purchase.
A link to download a PDF version of the trial profile will be included in your email receipt.

At a glance

Drugs Tuberculosis-vaccine-Archivel-Farma (Primary)
Indications Tuberculosis
Focus Adverse reactions
Sponsors Archivel Farma

Most Recent Events

30 Jun 2022 Status changed from recruiting to discontinued.
16 Jun 2021 Planned End Date changed from 1 Jul 2020 to 1 Sep 2021.
16 Jun 2021 Planned primary completion date changed from 1 Jan 2020 to 1 Sep 2021.

You need to be a logged in or subscribed to view this content Request demo

If your organization or you do not have a subscription, try one of the following:

Contacting your organization’s admin about adding this content to your AdisInsight subscription
Buying a PDF version of any individual profile
Request a free trial

If your organization has a subscription, there are several access options, even while working remotely:

Working within your organization’s network
Login with username/password or try to access via your institution
Persisted access using your organization’s identifier stored in your user browser for 90 days

For assistance, contact us at asktheexpert.adisinsight@springer.com

Welcome to AdisInsight